Should a Struggling Medtech Company Get a Second Chance: Interview With IONIQ CEO Jared Bauer

October 28, 2021

IONIQ CEO, Jared Bauer – a self-described “heavy thinker” was featured in a recent episode of Medsider.

Bauer explains the two key factors he looks at when determining whether a medical device company is worth trying to turn around, why finding investors who really care about your mission is a strategic benefit, and why he hopes that IONIQ’s devices will one day have a place in your medicine cabinet.

IONIQ Sciences, using bioimpedance, is developing a device that can potentially detect cancers in early stages. The company’s device was granted a breakthrough designation for lung cancer by the FDA in 2020.

Read More & Listen to the Interview »